.webp)
Description
Tofacent 5 mg Tablet is an oral medication manufactured by Incepta Pharmaceuticals Ltd., containing Tofacitinib as the active ingredient. Tofacitinib is a Janus kinase (JAK) inhibitor used to treat autoimmune diseases by suppressing overactive immune responses. It is primarily indicated for adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, especially in cases where patients have not responded well to conventional treatments like methotrexate. By inhibiting JAK enzymes involved in the inflammatory process, Tofacent helps reduce joint pain, swelling, and tissue damage in arthritis and improves symptoms in ulcerative colitis. The tablet is usually taken twice daily, with or without food, and requires careful monitoring due to potential risks such as infections and changes in blood cell counts. Tofacent offers an effective oral alternative to injectable biologics in managing chronic inflammatory conditions.
.jpeg)
.jpg)
.jpg)
.jpg)
.png)
.webp)
.jpeg)
.webp)
 400MG.jpg)
.jpeg)
 100 IU 3 ML.webp)
.webp)
.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)
.jpg)
Change Language